{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T06:14:09Z","timestamp":1779257649265,"version":"3.51.4"},"reference-count":141,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:p>The escalating global crisis of bacterial antimicrobial resistance (AMR) has significantly limited the clinical efficacy of quinolone antibiotics, while the use of phages alone suffers from inherent limitations, including a narrow host spectrum and the propensity to rapidly induce phage resistance. Consequently, combined antimicrobial therapy, defined as phage-antibiotic synergy (PAS), has emerged as a pivotal direction to address the challenges. The specific objectives of this review are to systematically dissect the bidirectional synergistic and antagonistic interactions between quinolone antibiotics and bacteriophages, define the key regulatory factors governing their combined effects, and establish an evidence-based framework to guide the standardized clinical application of quinolone-based PAS. This paper systematically reviews the mechanisms underlying the synergistic and antagonistic interactions between quinolone antibiotics and bacteriophages. The synergistic effects are manifested across multiple dimensions: bacterial morphological remodeling, activation of temperate phages, disruption of biofilm barriers, potentiation of functional proteins, dual regulation of resistance evolution, and synergy with the host immune system. In contrast, antagonistic effects are primarily triggered by high-concentration antibiotics interfering with phage proliferation, adaptive phenotypic alterations of bacteria, and imbalanced administration strategies. Simultaneously, we summarize standardized clinical optimization strategies, including sequential administration, sub-inhibitory antibiotic concentrations paired with the minimum effective multiplicity of infection (MOI) of phages, rational selection of broad-host-range and highly lytic phages, and individual regimen tailoring to match the specific infectious scenario and host immune status. We further analyze key challenges in the clinical translation of this therapeutic approach and propose future research directions, offering a framework to guide both mechanistic studies and clinical implementation of PAS as a strategy to mitigate antimicrobial resistance.<\/jats:p>","DOI":"10.3389\/fmicb.2026.1846582","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T05:48:03Z","timestamp":1779256083000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Phage-quinolone synergy: mechanisms, clinical strategies, and translational prospects"],"prefix":"10.3389","volume":"17","author":[{"given":"Xinrong","family":"Li","sequence":"first","affiliation":[{"name":"Department of Burn and Plastic Surgery, Medical Innovation Technology Transformation Center, Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University","place":["Shenzhen, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shangsheng","family":"Yao","sequence":"additional","affiliation":[{"name":"Department of Burn and Plastic Surgery, Medical Innovation Technology Transformation Center, Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University","place":["Shenzhen, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guangtao","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Burn and Plastic Surgery, Medical Innovation Technology Transformation Center, Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University","place":["Shenzhen, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,20]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3390\/antibiotics8030103","article-title":"Synergistic action of phage and antibiotics: parameters to enhance the killing efficacy against mono and dual-species biofilms","volume":"8","author":"Akturk","year":"2019","journal-title":"Antibiotics"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"109172","DOI":"10.1016\/j.celrep.2021.109172","article-title":"Temperate phage-antibiotic synergy eradicates bacteria through depletion of lysogens","volume":"35","author":"Al-Anany","year":"2021","journal-title":"Cell Rep."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"e00504-24","DOI":"10.1128\/mbio.00504-24","article-title":"Temperate phage-antibiotic synergy across antibiotic classes reveals new mechanism for preventing lysogeny","volume":"15","author":"Al-Anany","year":"2024","journal-title":"MBio"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"e13077","DOI":"10.1016\/j.heliyon.2023.e13077","article-title":"Evaluation of phage\u2014antibiotic combinations in the treatment of extended-spectrum \u03b2-lactamase-producing Salmonella enteritidis strain PT1","volume":"9","author":"Alharbi","year":"2023","journal-title":"Heliyon"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s12602-026-10928-9","article-title":"Antimicrobial Armageddon: the professional guide to conquering antibiotic resistance","author":"AlJerf","year":"2026","journal-title":"Probiotics Antimicrob. Proteins."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.2147\/IDR.S173867","article-title":"Antibiotic resistance: a rundown of a global crisis","volume":"11","author":"Aslam","year":"2018","journal-title":"Infect Drug Resist"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3390\/microorganisms10010046","article-title":"Bacteriophages: combating antimicrobial resistance in food-borne bacteria prevalent in agriculture","volume":"10","author":"Au","year":"2021","journal-title":"Microorganisms"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"9582","DOI":"10.1038\/s41598-021-88977-z","article-title":"Emergence of fluoroquinolone resistance and possible mechanisms in clinical isolates of Stenotrophomonas maltophilia from Iran","volume":"11","author":"Azimi","year":"2021","journal-title":"Sci. Rep."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"109846","DOI":"10.1016\/j.enzmictec.2021.109846","article-title":"Cloning and expression analysis of fused holin-endolysin from RL bacteriophage; exhibits broad activity against multi drug resistant pathogens","volume":"149","author":"Basit","year":"2021","journal-title":"Enzym. Microb. Technol."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.ijantimicag.2015.04.008","article-title":"Fluoroquinolone induction of phage-mediated gene transfer in multidrug-resistant Salmonella","volume":"46","author":"Bearson","year":"2015","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"e2507914122","DOI":"10.1073\/pnas.2507914122","article-title":"The role of innate immunity, antibiotics, and bacteriophages in the course of bacterial infections and their treatment","volume":"122","author":"Berryhill","year":"2025","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"9620","DOI":"10.1039\/d4sc00995a","article-title":"Development of an inhibitor of the mutagenic SOS response that suppresses the evolution of quinolone antibiotic resistance","volume":"15","author":"Bradbury","year":"2024","journal-title":"Chem. Sci."},{"key":"ref13","article-title":"Sub-therapeutic concentrations of antibiotics induce prophage-driven superinfection exclusion and fitness cost in Pseudomonas aeruginosa","volume-title":"bioRxiv.","author":"Bucher","year":"2024"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"e1013546","DOI":"10.1371\/journal.ppat.1013546","article-title":"Antibiotic-induced morphological changes enhance phage predation","volume":"21","author":"Bulssico","year":"2025","journal-title":"PLoS Pathog."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"e1011602","DOI":"10.1371\/journal.ppat.1011602","article-title":"Phage-antibiotic synergy: cell filamentation is a key driver of successful phage predation","volume":"19","author":"Bulssico","year":"2023","journal-title":"PLoS Pathog."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"11207","DOI":"10.1073\/pnas.1919888117","article-title":"Pleiotropy complicates a trade-off between phage resistance and antibiotic resistance","volume":"117","author":"Burmeister","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"769","DOI":"10.2217\/fmb.13.47","article-title":"Phage cocktails and the future of phage therapy","volume":"8","author":"Chan","year":"2013","journal-title":"Future Microbiol."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1208\/s12248-019-0315-0","article-title":"Bacteriophage PEV20 and ciprofloxacin combination treatment enhances removal of P. aeruginosa biofilm isolated from cystic fibrosis and wound patients","volume":"21","author":"Chang","year":"2019","journal-title":"AAPS J."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"893","DOI":"10.3389\/fmicb.2015.00893","article-title":"Update on infections caused by Stenotrophomonas maltophilia with particular attention to resistance mechanisms and therapeutic options","volume":"6","author":"Chang","year":"2015","journal-title":"Front. Microbiol."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"e0168615","DOI":"10.1371\/journal.pone.0168615","article-title":"Synergy and order effects of antibiotics and phages in killing Pseudomonas aeruginosa biofilms","volume":"12","author":"Chaudhry","year":"2017","journal-title":"PLoS One"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1038\/s41467-025-68136-y","article-title":"Timely bespoke phage-antibiotic combination to treat refractory Pseudomonas aeruginosa mediastinitis and vascular graft infection","volume":"17","author":"Chung","year":"2026","journal-title":"Nat. Commun."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"e799","DOI":"10.1371\/journal.pone.0000799","article-title":"Phage-antibiotic synergy (PAS): \u03b2-lactam and quinolone antibiotics stimulate virulent phage growth","volume":"2","author":"Comeau","year":"2007","journal-title":"PLoS One"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/s41591-019-0437-z","article-title":"Engineered bacteriophages for treatment of a patient with a disseminated drug resistant Mycobacterium abscessus","volume":"25","author":"Dedrick","year":"2019","journal-title":"Nat. Med."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1093\/jac\/dkt063","article-title":"Impact of qnrA1, qnrB1 and qnrS1 on the efficacy of ciprofloxacin and levofloxacin in an experimental pneumonia model caused by Escherichia coli with or without the GyrA mutation Ser83Leu","volume":"68","author":"Dom\u00ednguez-Herrera","year":"2013","journal-title":"J. Antimicrob. Chemother."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1719066","DOI":"10.3389\/fmicb.2025.1719066","article-title":"Fluoroquinolone resistance in ESKAPE pathogens: evolutionary pathways, one health transmission, and clinical surveillance","volume":"16","author":"Elbehiry","year":"2025","journal-title":"Front. Microbiol."},{"key":"ref26","doi-asserted-by":"publisher","first-page":"184","DOI":"10.3390\/ph14030184","article-title":"Synergistic killing and re-sensitization of Pseudomonas aeruginosa to antibiotics by phage-antibiotic combination treatment","volume":"14","author":"Engeman","year":"2021","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"e70193","DOI":"10.1111\/1751-7915.70193","article-title":"Phage-antibiotic combinations for Pseudomonas: successes in the clinic and in vitro tenuously connected","volume":"18","author":"Fatima","year":"","journal-title":"Microb. Biotechnol."},{"key":"ref28","doi-asserted-by":"publisher","first-page":"e02559-24","DOI":"10.1128\/mbio.02559-24","article-title":"Temperate phage-antibiotic synergy is widespread\u2014extending to Pseudomonas\u2014but varies by phage, host strain, and antibiotic pairing","volume":"16","author":"Fatima","year":"","journal-title":"MBio"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"e01621-25","DOI":"10.1128\/mbio.01621-25","article-title":"Temperate phages increase antibiotic effectiveness in a Caenorhabditis elegans infection model","volume":"16","author":"Fatima","year":"","journal-title":"MBio"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/nrmicro.2016.94","article-title":"Biofilms: an emergent form of bacterial life","volume":"14","author":"Flemming","year":"2016","journal-title":"Nat. Rev. Microbiol."},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1631359","DOI":"10.3389\/fcimb.2025.1631359","article-title":"Regulation of phage therapy medicinal products: developments, challenges, and opportunities","volume":"15","author":"Fuerst-Wilmes","year":"2025","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref32","doi-asserted-by":"publisher","first-page":"107655","DOI":"10.1016\/j.ijantimicag.2025.107655","article-title":"Antibiotic-mediated prophage activation: mechanisms, consequences, and therapeutic implications","volume":"67","author":"Gavric","year":"2026","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1016\/S0140-6736(24)01867-1","article-title":"Global burden of bacterial antimicrobial resistance 1990\u20132021: a systematic analysis with forecasts to 2050","volume":"404","year":"2024","journal-title":"Lancet"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"2","DOI":"10.2174\/138920110790725311","article-title":"Phage choice, isolation, and preparation for phage therapy","volume":"11","author":"Gill","year":"2010","journal-title":"Curr. Pharm. Biotechnol."},{"key":"ref35","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/j.1365-2672.2009.04469.x","article-title":"Bacteriophage-derived enzyme that depolymerizes the alginic acid capsule associated with cystic fibrosis isolates of Pseudomonas aeruginosa","volume":"108","author":"Glonti","year":"2010","journal-title":"J. Appl. Microbiol."},{"key":"ref36","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1093\/nar\/gku1330","article-title":"Function of the N-terminal segment of the RecA-dependent nuclease ref","volume":"43","author":"Gruber","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"ref37","doi-asserted-by":"publisher","first-page":"2273567","DOI":"10.1080\/21505594.2023.2273567","article-title":"Potential of phage depolymerase for the treatment of bacterial biofilms","volume":"14","author":"Guo","year":"2023","journal-title":"Virulence"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.copbio.2020.08.014","article-title":"Lysins breaking down the walls of gram-negative bacteria, no longer a no-go","volume":"68","author":"Guti\u00e9rrez","year":"2021","journal-title":"Curr. Opin. Biotechnol."},{"key":"ref39","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1556\/030.63.2016.011","article-title":"Detection of acrA, acrB, aac(6\u2032)-Ib-cr, and qepA genes among clinical isolates of Escherichia coli and Klebsiella pneumoniae","volume":"64","author":"Heidary","year":"2017","journal-title":"Acta Microbiol. Immunol. Hung."},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.110372","article-title":"Metabolic reprogramming of Pseudomonas aeruginosa by phage-based quorum sensing modulation","volume":"38","author":"Hendrix","year":"2022","journal-title":"Cell Rep."},{"key":"ref41","doi-asserted-by":"publisher","first-page":"ftz011","DOI":"10.1093\/femspd\/ftz011","article-title":"P. aeruginosa flow-cell biofilms are enhanced by repeated phage treatments but can be eradicated by phage\u2013ciprofloxacin combination: \u2014monitoring the phage\u2013P. aeruginosa biofilms interactions","volume":"77","author":"Henriksen","year":"2019","journal-title":"Pathog. Dis."},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.3201\/eid2305.et2305","article-title":"Etymologia: fluoroquinolone","volume":"23","author":"Henry","year":"2017","journal-title":"Emerg. Infect. Dis. J."},{"key":"ref43","doi-asserted-by":"crossref","DOI":"10.1101\/2025.08.30.673261","article-title":"Gabija restricts phages that antagonize a conserved host DNA repair complex","author":"Hong","year":"2025"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/nyas.12830","article-title":"Mechanisms of drug resistance: quinolone resistance","volume":"1354","author":"Hooper","year":"2015","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref45","doi-asserted-by":"publisher","first-page":"a025320","DOI":"10.1101\/cshperspect.a025320","article-title":"Topoisomerase inhibitors: fluoroquinolone mechanisms of action and resistance","volume":"6","author":"Hooper","year":"2016","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref46","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/s41598-022-26696-9","article-title":"Characterisation and sequencing of the novel phage Abp95, which is effective against multi-genotypes of carbapenem-resistant Acinetobacter baumannii","volume":"13","author":"Huang","year":"2023","journal-title":"Sci. Rep."},{"key":"ref47","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1186\/s12879-014-0681-2","article-title":"Antibacterial properties of Acinetobacter baumanniiphage Abp1 endolysin (PlyAB1)","volume":"14","author":"Huang","year":"2014","journal-title":"BMC Infect. Dis."},{"key":"ref48","doi-asserted-by":"publisher","first-page":"2468114","DOI":"10.1080\/20565623.2025.2468114","article-title":"Unveiling the potential bacteriophage therapy: a systematic review","volume":"11","author":"Ibrahim","year":"2025","journal-title":"Future Sci. OA"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1111\/jam.14241","article-title":"Antibiofilm potential of purified environmental bacteriophage preparations against early stage Pseudomonas aeruginosa biofilms","volume":"126","author":"Issa","year":"2019","journal-title":"J. Appl. Microbiol."},{"key":"ref50","doi-asserted-by":"publisher","first-page":"104726","DOI":"10.1016\/j.micpath.2020.104726","article-title":"Evaluation of phage adsorption to Salmonella Typhimurium exposed to different levels of pH and antibiotic","volume":"150","author":"Jeon","year":"2021","journal-title":"Microb. Pathog."},{"key":"ref51","doi-asserted-by":"publisher","first-page":"113741","DOI":"10.1016\/j.ejmech.2021.113741","article-title":"The antibacterial activity of fluoroquinolone derivatives: an update (2018-2021)","volume":"224","author":"Jia","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"ref52","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1007\/s10068-016-0153-0","article-title":"Synergistic antimicrobial activity of bacteriophages and antibiotics against Staphylococcus aureus","volume":"25","author":"Jo","year":"","journal-title":"Food Sci. Biotechnol."},{"key":"ref53","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1007\/s10068-016-0192-6","article-title":"Role of phage-antibiotic combination in reducing antibiotic resistance in Staphylococcus aureus","volume":"25","author":"Jo","year":"","journal-title":"Food Sci. Biotechnol."},{"key":"ref54","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.3390\/ijms26041755","article-title":"Re-emergence of bacteriophages and their products as antibacterial agents: an overview","volume":"26","author":"Kalia","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"ref55","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.jgar.2025.10.012","article-title":"Isolation and in vitro evaluation of bacteriophages against Pseudomonas aeruginosa isolated from burn wounds of human patients and hospital environment","volume":"46","author":"Kanwar","year":"2026","journal-title":"J. Global Antimicrob. Resist."},{"key":"ref56","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1111\/cbdd.14025","article-title":"Emerging quinoline- and quinolone-based antibiotics in the light of epidemics","volume":"100","author":"Kaur","year":"2022","journal-title":"Chem. Biol. Drug Des."},{"key":"ref57","doi-asserted-by":"publisher","first-page":"121206","DOI":"10.1016\/j.ijpharm.2021.121206","article-title":"Enteric-coated bacteriophage tablets for oral administration against gastrointestinal infections","volume":"609","author":"Khanal","year":"2021","journal-title":"Int. J. Pharm."},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2025.110649","article-title":"Targeting bacterial persistence with bacteriophages: a next-generation antimicrobial strategy","volume":"611","author":"Kim","year":"2025","journal-title":"Virology"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"e02085","DOI":"10.1128\/AEM.02085-18","article-title":"Phage-antibiotic synergy via delayed lysis","volume":"84","author":"Kim","year":"2018","journal-title":"Appl. Environ. Microbiol."},{"key":"ref60","doi-asserted-by":"publisher","first-page":"107612","DOI":"10.1016\/j.ijantimicag.2025.107612","article-title":"The prospect of approved and commercially available phage therapeutics","volume":"66","author":"K\u00f6nig","year":"2025","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1186\/s12879-019-4606-y","article-title":"Impact of co-existence of PMQR genes and QRDR mutations on fluoroquinolones resistance in Enterobacteriaceae strains isolated from community and hospital acquired UTIs","volume":"19","author":"Kotb","year":"2019","journal-title":"BMC Infect. Dis."},{"key":"ref62","doi-asserted-by":"publisher","first-page":"58","DOI":"10.47183\/mes.2024-26-4-58-65","article-title":"Effect of combinations of antibiotics, phages, and depolymerase on biofilms of the drug-resistant Klebsiella pneumoniae strain","volume":"26","author":"Krivulia","year":"2024","journal-title":"Extreme Med."},{"key":"ref63","doi-asserted-by":"publisher","first-page":"9911","DOI":"10.1093\/nar\/gkt749","article-title":"Structure of an \u2018open\u2019 clamp type II topoisomerase-DNA complex provides a mechanism for DNA capture and transport","volume":"41","author":"Laponogov","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"ref64","doi-asserted-by":"publisher","first-page":"20338","DOI":"10.1038\/s41598-020-77198-5","article-title":"Advantages and limitations of microtiter biofilm assays in the model of antibiofilm activity of Klebsiella phage KP34 and its depolymerase","volume":"10","author":"Latka","year":"2020","journal-title":"Sci. Rep."},{"key":"ref65","doi-asserted-by":"publisher","first-page":"e04430-22","DOI":"10.1128\/spectrum.04430-22","article-title":"Synergistic interactions among Burkholderia cepacia complex-targeting phages reveal a novel therapeutic role for lysogenization-capable phages","volume":"11","author":"Lauman","year":"2023","journal-title":"Microbiol. Spectrum"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"e01060-24","DOI":"10.1128\/msystems.01060-24","article-title":"Protein aggregation is a consequence of the dormancy-inducing membrane toxin TisB in Escherichia coli","volume":"9","author":"Leinberger","year":"2024","journal-title":"mSystems"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s00284-023-03295-z","article-title":"Acinetobacter baumannii bacteriophage: Progress in isolation, genome sequencing, preclinical research, and clinical application","volume":"80","author":"Li","year":"2023","journal-title":"Curr. Microbiol."},{"key":"ref68","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.ijpharm.2018.09.024","article-title":"Synergy of nebulized phage PEV20 and ciprofloxacin combination against Pseudomonas aeruginosa","volume":"551","author":"Lin","year":"2018","journal-title":"Int. J. Pharm."},{"key":"ref69","doi-asserted-by":"publisher","first-page":"162","DOI":"10.4292\/wjgpt.v8.i3.162","article-title":"Phage therapy: an alternative to antibiotics in the age of multi-drug resistance","volume":"8","author":"Lin","year":"2017","journal-title":"World J. Gastrointest. Pharmacol. Ther."},{"key":"ref70","doi-asserted-by":"publisher","first-page":"119952","DOI":"10.1016\/j.ijpharm.2020.119952","article-title":"Storage stability of phage-ciprofloxacin combination powders against Pseudomonas aeruginosa respiratory infections","volume":"591","author":"Lin","year":"2020","journal-title":"Int. J. Pharm."},{"key":"ref71","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1007\/s00203-023-03803-6","article-title":"A bacteriophage against Citrobacter braakii and its synergistic effect with antibiotics","volume":"206","author":"Liu","year":"2024","journal-title":"Arch. Microbiol."},{"key":"ref72","doi-asserted-by":"publisher","first-page":"125","DOI":"10.3390\/microorganisms6040125","article-title":"Sequential combined effect of phages and antibiotics on the inactivation of Escherichia coli","volume":"6","author":"Lopes","year":"2018","journal-title":"Microorganisms"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"668430","DOI":"10.3389\/fcimb.2021.668430","article-title":"Phage Endolysin LysP108 showed promising antibacterial potential against methicillin-resistant Staphylococcus aureus","volume":"11","author":"Lu","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/mdr.2010.0074","article-title":"Joint effects of topoisomerase alterations and plasmid-mediated quinolone-resistant determinants in Salmonella enterica Typhimurium","volume":"17","author":"Luo","year":"2011","journal-title":"Microb. Drug Resist."},{"key":"ref75","doi-asserted-by":"publisher","first-page":"e00448-24","DOI":"10.1128\/aac.00448-24","article-title":"Synergy of lytic phage pB23 and meropenem combination against carbapenem-resistant Acinetobacter baumannii","volume":"68","author":"Luo","year":"2024","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-026-69247-w","article-title":"Ecological partitioning enables phage\u2013antibiotic cooperation in a human Pseudomonas infection","volume":"17","author":"Luong","year":"2026","journal-title":"Nat. Commun."},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-026-27053-5","article-title":"Exploring antibiotic knowledge and practices in a sample of Damascus residents: a foundation for informed interventions and public health strategies","author":"Maad","year":"2026","journal-title":"BMC Public Health"},{"key":"ref78","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.3390\/pathogens14101011","article-title":"Phage to ESKAPE: personalizing therapy for MDR infections\u2014a comprehensive clinical review","volume":"14","author":"Marino","year":"2025","journal-title":"Pathogens"},{"key":"ref79","doi-asserted-by":"publisher","first-page":"4738","DOI":"10.1128\/jb.175.15.4738-4743.1993","article-title":"In vivo studies on the interaction of RecBCD enzyme and lambda gam protein","volume":"175","author":"Marsi\u0107","year":"1993","journal-title":"J. Bacteriol."},{"key":"ref80","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.3390\/microorganisms12091795","article-title":"The potential of phage treatment to inactivate planktonic and biofilm-forming Pseudomonas aeruginosa","volume":"12","author":"Martinho","year":"2024","journal-title":"Microorganisms"},{"key":"ref81","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.3389\/fmicb.2015.01271","article-title":"On-demand isolation of bacteriophages against drug-resistant Bacteria for personalized phage therapy","volume":"6","author":"Mattila","year":"2015","journal-title":"Front. Microbiol."},{"key":"ref82","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.coviro.2021.12.003","article-title":"Engineering therapeutic phages for enhanced antibacterial efficacy","volume":"52","author":"Meile","year":"2022","journal-title":"Curr. Opin. Virol."},{"key":"ref83","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1038\/s41579-024-01054-w","article-title":"ESKAPE pathogens: antimicrobial resistance, epidemiology, clinical impact and therapeutics","volume":"22","author":"Miller","year":"2024","journal-title":"Nat. Rev. Microbiol."},{"key":"ref84","doi-asserted-by":"publisher","first-page":"e70280","DOI":"10.1002\/mco2.70280","article-title":"Phage and endolysin therapy against antibiotics resistant bacteria: from bench to bedside","volume":"6","author":"Moghadam","year":"2025","journal-title":"MedComm"},{"key":"ref85","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.tim.2018.10.008","article-title":"Phage therapy: going temperate?","volume":"27","author":"Monteiro","year":"2019","journal-title":"Trends Microbiol."},{"key":"ref86","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.3389\/fmicb.2018.01696","article-title":"Applications of bacteriophages in the treatment of localized infections in humans","volume":"9","author":"Morozova","year":"2018","journal-title":"Front. Microbiol."},{"key":"ref87","doi-asserted-by":"publisher","first-page":"107673","DOI":"10.1016\/j.ijantimicag.2025.107673","article-title":"Phage therapy for KPC-producing Klebsiella pneumoniae decolonization in high-risk patients: the KIDNAP study protocol \u2013 a prospective feasibility and proof of concept study in the Brazilian context","volume":"67","author":"Najjar","year":"2026","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref88","doi-asserted-by":"publisher","first-page":"712","DOI":"10.3390\/antibiotics11060712","article-title":"Synergistic effects of bacteriophage vB_Eco4-M7 and selected antibiotics on the biofilm formed by Shiga toxin-producing Escherichia coli","volume":"11","author":"Necel","year":"2022","journal-title":"Antibiotics (Basel)"},{"key":"ref89","doi-asserted-by":"publisher","first-page":"107705","DOI":"10.1016\/j.ijantimicag.2025.107705","article-title":"Pharmacokinetics and pharmacodynamics of bacteriophage therapy: a scoping review","volume":"67","author":"Nguyen","year":"2026","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref90","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.3390\/v14071542","article-title":"An optimized checkerboard method for phage-antibiotic synergy detection","volume":"14","author":"Nikolic","year":"2022","journal-title":"Viruses"},{"key":"ref91","doi-asserted-by":"publisher","first-page":"215","DOI":"10.37349\/emed.2024.00217","article-title":"Medicinal and immunological aspects of bacteriophage therapy to combat antibiotic resistance","volume":"5","author":"Noor","year":"2024","journal-title":"Explor. Med."},{"key":"ref92","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1093\/infdis\/jiw632","article-title":"Synergistic interaction between phage therapy and antibiotics clears Pseudomonas Aeruginosa infection in endocarditis and reduces virulence","volume":"215","author":"Oechslin","year":"2017","journal-title":"J. Infect. Dis."},{"key":"ref93","doi-asserted-by":"publisher","first-page":"102949","DOI":"10.1016\/j.xpro.2024.102949","article-title":"Protocol for phage matching, treatment, and monitoring for compassionate bacteriophage use in non-resolving infections","volume":"5","author":"Onallah","year":"2024","journal-title":"STAR Protocols"},{"key":"ref94","doi-asserted-by":"publisher","first-page":"e3002952","DOI":"10.1371\/journal.pbio.3002952","article-title":"Chloramphenicol and gentamicin reduce the evolution of resistance to phage \u03a6X174 by suppressing a subset of E. coli LPS mutants","volume":"23","author":"Parab","year":"2025","journal-title":"PLoS Biol."},{"key":"ref95","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1093\/jac\/dkaf163","article-title":"Reversal of phenotypic resistance in multi-drug resistant carbapenemase-producing K. pneumoniae clinical isolates due to in vitro synergistic interactions between bacteriophages and antibiotics at clinically achievable concentrations","volume":"80","author":"Paranos","year":"","journal-title":"J. Antimicrob. Chemother."},{"key":"ref96","doi-asserted-by":"publisher","first-page":"343","DOI":"10.3390\/ph18030343","article-title":"In vitro interactions between bacteriophages and antibacterial agents of various classes against multidrug-resistant Metallo-\u03b2-lactamase-producing Pseudomonas aeruginosa clinical isolates","volume":"18","author":"Paranos","year":"","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref97","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1002\/jcph.715","article-title":"Safety concerns surrounding quinolone use in children","volume":"56","author":"Patel","year":"2016","journal-title":"J. Clin. Pharmacol."},{"key":"ref98","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.14202\/vetworld.2022.2039-2045","article-title":"Broad lytic spectrum of novel Salmonella phages on ciprofloxacin-resistant Salmonella contaminated in the broiler production chain","volume":"15","author":"Pelyuntha","year":"2022","journal-title":"Vet. World"},{"key":"ref99","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1007\/s10068-018-0351-z","article-title":"Combined effect of bacteriophage and antibiotic on the inhibition of the development of antibiotic resistance in Salmonella typhimurium","volume":"27","author":"Petsong","year":"2018","journal-title":"Food Sci. Biotechnol."},{"key":"ref100","doi-asserted-by":"publisher","first-page":"5239","DOI":"10.1128\/JB.00173-08","article-title":"The \u025b subunit of DNA polymerase III is involved in the Nalidixic acid-induced SOS response in Escherichia coli","volume":"190","author":"Pohlhaus","year":"2008","journal-title":"J. Bacteriol."},{"key":"ref101","doi-asserted-by":"publisher","first-page":"183935","DOI":"10.1016\/j.bbamem.2022.183935","article-title":"Modification of bacterial cell membrane dynamics and morphology upon exposure to sub inhibitory concentrations of ciprofloxacin","volume":"1864","author":"Ponmalar","year":"2022","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"ref102","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.molcel.2019.03.015","article-title":"Molecular basis of phage communication","volume":"74","author":"Rajaure","year":"2019","journal-title":"Mol. Cell"},{"key":"ref103","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41538-023-00245-8","article-title":"Positive and negative aspects of bacteriophages and their immense role in the food chain","volume":"8","author":"Ranveer","year":"2024","journal-title":"NPJ Sci. Food"},{"key":"ref104","doi-asserted-by":"publisher","first-page":"e1316","DOI":"10.1002\/mbo3.1316","article-title":"Defects in DNA double-strand break repair resensitize antibiotic-resistant Escherichia coli to multiple bactericidal antibiotics","volume":"11","author":"Revitt-Mills","year":"2022","journal-title":"Microbiology"},{"key":"ref105","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.chom.2017.06.018","article-title":"Synergy between the host immune system and bacteriophage is essential for successful phage therapy against an acute respiratory pathogen","volume":"22","author":"Roach","year":"2017","journal-title":"Cell Host Microbe"},{"key":"ref106","doi-asserted-by":"publisher","first-page":"525","DOI":"10.3390\/pathogens14060525","article-title":"The rise, fall, and rethink of (Fluoro)quinolones: a quick rundown","volume":"14","author":"Rodrigues","year":"2025","journal-title":"Pathogens"},{"key":"ref107","doi-asserted-by":"publisher","first-page":"e1005797","DOI":"10.1371\/journal.pgen.1005797","article-title":"P1 ref endonuclease: a molecular mechanism for phage-enhanced antibiotic lethality","volume":"12","author":"Ronayne","year":"2016","journal-title":"PLoS Genet."},{"key":"ref108","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1089\/mdr.2021.0324","article-title":"Bacteriophage-ciprofloxacin combination effectiveness depends on Staphylococcus aureus-Candida albicans dual-species communities\u2019 growth model","volume":"28","author":"Roszak","year":"2022","journal-title":"Microb. Drug Resist."},{"key":"ref109","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.ijantimicag.2012.02.011","article-title":"Transferable mechanisms of quinolone resistance","volume":"40","author":"Ruiz","year":"2012","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref110","doi-asserted-by":"publisher","first-page":"95826","DOI":"10.5501\/wjv.v14.i2.95826","article-title":"Synergistic efficacy of phages along with vancomycin for eradication of vancomycin-resistant Enterococcus faecalis biofilms","volume":"14","author":"Sahu","year":"2025","journal-title":"World J. Virol."},{"key":"ref111","doi-asserted-by":"publisher","first-page":"2749","DOI":"10.1007\/s10123-025-00727-7","article-title":"Combating multidrug-resistant uropathogenic E. coli using lytic phages, enhancing antibiotic synergy and inhibiting biofilms","volume":"28","author":"Shamsuzzaman","year":"2025","journal-title":"Int. Microbiol."},{"key":"ref112","doi-asserted-by":"publisher","first-page":"1025633","DOI":"10.3389\/fpubh.2022.1025633","article-title":"The resistance mechanisms of bacteria against ciprofloxacin and new approaches for enhancing the efficacy of this antibiotic","volume":"10","author":"Shariati","year":"2022","journal-title":"Front. Public Health"},{"key":"ref113","doi-asserted-by":"publisher","first-page":"e24932","DOI":"10.1002\/jcla.24932","article-title":"Bacteriophages: the promising therapeutic approach for enhancing ciprofloxacin efficacy against bacterial infection","volume":"37","author":"Shariati","year":"2023","journal-title":"J. Clin. Lab. Anal."},{"key":"ref114","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1099\/jgv.0.000428","article-title":"Identification and characterization of HolGH15: the holin of Staphylococcus aureus bacteriophage GH15","volume":"97","author":"Song","year":"2016","journal-title":"J. Gen. Virol."},{"key":"ref115","doi-asserted-by":"publisher","first-page":"e000198","DOI":"10.1099\/mgen.0.000198","article-title":"Trends in fluoroquinolone resistance in Campylobacter","volume":"4","author":"Sproston","year":"2018","journal-title":"Microbial Genomics"},{"key":"ref116","doi-asserted-by":"publisher","first-page":"545","DOI":"10.3390\/antibiotics14060545","article-title":"The current landscape of phage\u2013antibiotic synergistic (PAS) interactions","volume":"14","author":"Supina","year":"2025","journal-title":"Antibiotics (Basel)"},{"key":"ref117","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/S1473-3099(17)30753-3","article-title":"Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis","volume":"18","author":"Tacconelli","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"ref118","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3389\/fcimb.2019.00022","article-title":"Fighting pathogenic Bacteria on two fronts: phages and antibiotics as combined strategy","volume":"9","author":"Tagliaferri","year":"2019","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref119","doi-asserted-by":"publisher","first-page":"e0182225","DOI":"10.1128\/mbio.01822-25","article-title":"Reprogramming resistance: phage-antibiotic synergy targets efflux systems in ESKAPEE pathogens","volume":"16","author":"Tarasenko","year":"2025","journal-title":"MBio"},{"key":"ref120","doi-asserted-by":"publisher","first-page":"2671","DOI":"10.1128\/AAC.02972-15","article-title":"Novel engineered peptides of a phage Lysin as effective antimicrobials against multidrug-resistant Acinetobacter baumannii","volume":"60","author":"Thandar","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref121","doi-asserted-by":"publisher","first-page":"695","DOI":"10.3389\/fmicb.2020.00695","article-title":"Using bacteriophages as a Trojan horse to the killing of dual-species biofilm formed by Pseudomonas aeruginosa and methicillin resistant Staphylococcus aureus","volume":"11","author":"Tkhilaishvili","year":"2020","journal-title":"Front. Microbiol."},{"key":"ref122","doi-asserted-by":"publisher","first-page":"2744","DOI":"10.1038\/ismej.2016.47","article-title":"Genetic and life-history traits associated with the distribution of prophages in bacteria","volume":"10","author":"Touchon","year":"2016","journal-title":"ISME J."},{"key":"ref123","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1111\/j.1365-2958.2005.04584.x","article-title":"Antibiotic-induced SOS response promotes horizontal dissemination of pathogenicity island-encoded virulence factors in staphylococci","volume":"56","author":"Ubeda","year":"2005","journal-title":"Mol. Microbiol."},{"key":"ref124","doi-asserted-by":"publisher","first-page":"e00925-25","DOI":"10.1128\/aac.00925-25","article-title":"Impact of Pseudomonas aeruginosa biofilm exopolysaccharide composition on bacteriophage and bacteriophage-antibiotic combination activity","volume":"70","author":"Van Helden","year":"2025","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref125","doi-asserted-by":"publisher","first-page":"143093","DOI":"10.1016\/j.ijbiomac.2025.143093","article-title":"Diversity, structure-function relationships and evolution of cell wall-binding domains of staphylococcal phage endolysins","volume":"310","author":"V\u00e1zquez","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"ref126","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.coviro.2021.11.005","article-title":"European regulatory aspects of phage therapy: magistral phage preparations","volume":"52","author":"Verbeken","year":"2022","journal-title":"Curr. Opin. Virol."},{"key":"ref127","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1080\/08927014.2015.1131821","article-title":"Discrimination of bacteriophage infected cells using locked nucleic acid fluorescent in situ hybridization (LNA-FISH)","volume":"32","author":"Vilas Boas","year":"2016","journal-title":"Biofouling"},{"key":"ref128","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1126\/science.272.5270.1910","article-title":"Lysogenic conversion by a filamentous phage encoding cholera toxin","volume":"272","author":"Waldor","year":"1996","journal-title":"Science"},{"key":"ref129","doi-asserted-by":"publisher","first-page":"107276","DOI":"10.1016\/j.ijantimicag.2024.107276","article-title":"Bacteriophages as potential antibiotic potentiators in cystic fibrosis: a new model to study the combination of antibiotics with a bacteriophage cocktail targeting dual species biofilms of Staphylococcus aureus and Pseudomonas aeruginosa","volume":"64","author":"Wang","year":"2024","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref130","doi-asserted-by":"publisher","first-page":"107220","DOI":"10.1016\/j.ijantimicag.2024.107220","article-title":"Phage therapy combats pan drug-resistant Acinetobacter baumannii infection safely and efficiently","volume":"64","author":"Wang","year":"2024","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref131","doi-asserted-by":"publisher","first-page":"e22963","DOI":"10.7554\/eLife.22963","article-title":"Structural basis for the inhibition of RecBCD by gam and its synergistic antibacterial effect with quinolones","volume":"5","author":"Wilkinson","year":"2016","journal-title":"eLife"},{"key":"ref132","doi-asserted-by":"publisher","first-page":"e83409","DOI":"10.7554\/eLife.83409","article-title":"Structures of RecBCD in complex with phage-encoded inhibitor proteins reveal distinctive strategies for evasion of a bacterial immunity hub","volume":"11","author":"Wilkinson","year":"2022","journal-title":"eLife"},{"key":"ref133","doi-asserted-by":"publisher","first-page":"822","DOI":"10.3389\/fmicb.2019.00822","article-title":"Substantial contribution of SmeDEF, SmeVWX, SmQnr, and heat shock response to fluoroquinolone resistance in clinical isolates of Stenotrophomonas maltophilia","volume":"10","author":"Wu","year":"2019","journal-title":"Front. Microbiol."},{"key":"ref134","doi-asserted-by":"publisher","first-page":"1250848","DOI":"10.3389\/fmicb.2023.1250848","article-title":"Regulations of phage therapy across the world","volume":"14","author":"Yang","year":"2023","journal-title":"Front. Microbiol."},{"key":"ref135","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1093\/bioinformatics\/btx801","article-title":"Machine learning for classifying tuberculosis drug-resistance from DNA sequencing data","volume":"34","author":"Yang","year":"2018","journal-title":"Bioinformatics"},{"key":"ref136","doi-asserted-by":"publisher","first-page":"3843","DOI":"10.3390\/molecules25173843","article-title":"Activity of antimicrobial peptides and ciprofloxacin against Pseudomonas aeruginosa biofilms","volume":"25","author":"Yasir","year":"2020","journal-title":"Molecules"},{"key":"ref137","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s12275-014-4087-z","article-title":"Phage lysis: three steps, three choices, one outcome","volume":"52","author":"Young","year":"2014","journal-title":"J. Microbiol."},{"key":"ref138","doi-asserted-by":"publisher","first-page":"107886","DOI":"10.1016\/j.micpath.2025.107886","article-title":"Adaptive trade-offs between bacteriophage and antibiotic resistance in Salmonella Typhimurium","volume":"207","author":"Zhang","year":"2025","journal-title":"Microb. Pathog."},{"key":"ref139","article-title":"Kiwa is a bacterial membrane-embedded defence supercomplex activated by phage-induced membrane changes","author":"Zhang","year":"2025"},{"key":"ref140","doi-asserted-by":"publisher","first-page":"eadv4747","DOI":"10.1126\/sciadv.adv4747","article-title":"The two-component nuclease-active KELShedu system confers broad antiphage activity via abortive infection","volume":"11","author":"Zhang","year":"2025","journal-title":"Sci. Adv."},{"key":"ref141","doi-asserted-by":"publisher","first-page":"1499325","DOI":"10.3389\/fcimb.2024.1499325","article-title":"Synergistic efficacy of phage Henu10 with antibiotics against Shigella dysenteriae with insight into phage resistance and fitness trade-offs","volume":"14","author":"Zhao","year":"2024","journal-title":"Front. Cell. Infect. Microbiol."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2026.1846582\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T05:48:05Z","timestamp":1779256085000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2026.1846582\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,20]]},"references-count":141,"alternative-id":["10.3389\/fmicb.2026.1846582"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2026.1846582","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,20]]},"article-number":"1846582"}}